![logo](/logos/000919.SZ.webp)
Jinling Pharmaceutical Company Limited
SZSE:000919.SZ
7.85 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,785.738 | 2,670.968 | 2,808.755 | 2,503.732 | 2,534.921 | 2,899.079 | 3,191.812 | 3,578.653 | 3,221.375 | 2,771.942 | 2,605.714 | 2,304.934 | 2,257.023 | 2,161.139 | 1,966.706 | 1,788.882 | 1,548.969 | 1,375.734 | 1,235.8 | 1,001.753 | 849.717 | 629.56 | 499.417 | 364.95 | 354.136 | 339.045 | 301.396 | 196.834 |
Cost of Revenue
| 2,199.625 | 2,142.826 | 2,178.684 | 1,942.338 | 1,936.731 | 2,202.758 | 2,484.263 | 2,844.934 | 2,513.783 | 2,100.378 | 1,990.793 | 1,753.18 | 1,691.927 | 1,589.862 | 1,403.937 | 1,270.223 | 1,095.427 | 920.221 | 793.374 | 578.053 | 478.627 | 315.736 | 279.439 | 180.987 | 176.927 | 182.5 | 166.135 | 120.049 |
Gross Profit
| 586.113 | 528.142 | 630.071 | 561.395 | 598.19 | 696.321 | 707.548 | 733.719 | 707.593 | 671.565 | 614.921 | 551.755 | 565.096 | 571.278 | 562.769 | 518.659 | 453.542 | 455.514 | 442.426 | 423.7 | 371.089 | 313.824 | 219.979 | 183.963 | 177.209 | 156.545 | 135.261 | 76.785 |
Gross Profit Ratio
| 0.21 | 0.198 | 0.224 | 0.224 | 0.236 | 0.24 | 0.222 | 0.205 | 0.22 | 0.242 | 0.236 | 0.239 | 0.25 | 0.264 | 0.286 | 0.29 | 0.293 | 0.331 | 0.358 | 0.423 | 0.437 | 0.498 | 0.44 | 0.504 | 0.5 | 0.462 | 0.449 | 0.39 |
Reseach & Development Expenses
| 79.143 | 74.17 | 57.015 | 43.709 | 43.915 | 34.122 | 34.802 | 35.979 | 41.043 | 40.138 | 36.412 | 33.853 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 83.177 | 74.26 | 73.288 | 83.444 | 68.125 | 75.027 | 67.835 | 86.866 | 82.523 | 76.158 | 63.65 | 73.894 | 49.314 | 54.377 | 175.698 | 153.727 | 179.51 | 174.578 | 158.066 | 148.362 | 150.589 | 117.986 | 73.543 | 46.124 | 37.278 | 25.627 | 22.471 | 22.362 |
Selling & Marketing Expenses
| 86.166 | 85.999 | 99.316 | 63.796 | 76.033 | 164.004 | 166.195 | 131.554 | 131.517 | 140.237 | 129.87 | 127.389 | 109.296 | 135.728 | 127.024 | 117.638 | 104.594 | 96.397 | 72.496 | 69.106 | 68.999 | 37.143 | 46.5 | 18.598 | 7.919 | 11.587 | 9.343 | 15.406 |
SG&A
| 169.343 | 160.259 | 172.604 | 147.24 | 144.159 | 239.031 | 234.03 | 218.419 | 214.04 | 216.396 | 193.52 | 201.283 | 158.61 | 190.105 | 302.722 | 271.365 | 284.104 | 270.975 | 230.562 | 217.468 | 219.588 | 155.129 | 120.043 | 64.722 | 45.198 | 37.215 | 31.815 | 37.767 |
Other Expenses
| 1.423 | 231.233 | 223.795 | 188.853 | 212.883 | -2.285 | -4.603 | 0.274 | 9.397 | 1.648 | -2.55 | 8.595 | 0.106 | -0.304 | 5.994 | 2.294 | -1.434 | 3.777 | 1.68 | -1.497 | -0.184 | 0.123 | -0.25 | -2.641 | 3.804 | 2.97 | 5.795 | 1.653 |
Operating Expenses
| 506.264 | 465.662 | 453.414 | 379.803 | 400.957 | 487.233 | 496.747 | 463.663 | 459.496 | 425.531 | 390.933 | 359.562 | 304.66 | 314.185 | 313.49 | 281.788 | 293.508 | 279.767 | 239.159 | 226.009 | 228.052 | 162.005 | 125.806 | 69.088 | 49.367 | 41.074 | 35.056 | 39.711 |
Operating Income
| 116.998 | 94.644 | 197.171 | 180.362 | 340.402 | 363.829 | 222.813 | 283.001 | 322.014 | 305.164 | 245.829 | 218.023 | 261.968 | 274.431 | 300.988 | 108.205 | 425.501 | 279.767 | 213.114 | 152.455 | 181.231 | 177.852 | 155.234 | 146.508 | 132.569 | 120.368 | 102.138 | 34.777 |
Operating Income Ratio
| 0.042 | 0.035 | 0.07 | 0.072 | 0.134 | 0.125 | 0.07 | 0.079 | 0.1 | 0.11 | 0.094 | 0.095 | 0.116 | 0.127 | 0.153 | 0.06 | 0.275 | 0.203 | 0.172 | 0.152 | 0.213 | 0.283 | 0.311 | 0.401 | 0.374 | 0.355 | 0.339 | 0.177 |
Total Other Income Expenses Net
| 38.572 | 33.126 | -2.359 | -55.235 | -92.987 | 152.456 | 7.408 | 12.004 | 81.076 | 58.984 | 18.216 | 31.654 | -0.182 | 15.746 | 56.89 | -127.484 | 264.033 | 93.153 | 6.184 | -51.463 | 30.74 | 22.579 | 57.809 | 28.014 | 4.948 | -0.464 | -0.336 | -4.39 |
Income Before Tax
| 118.421 | 127.77 | 194.812 | 125.128 | 247.415 | 361.544 | 218.21 | 282.06 | 329.173 | 305.017 | 242.204 | 223.847 | 260.254 | 272.838 | 306.169 | 109.388 | 424.068 | 276.222 | 212.123 | 148.593 | 177.412 | 176.187 | 153.483 | 143.378 | 134.582 | 119.173 | 103.901 | 34.557 |
Income Before Tax Ratio
| 0.043 | 0.048 | 0.069 | 0.05 | 0.098 | 0.125 | 0.068 | 0.079 | 0.102 | 0.11 | 0.093 | 0.097 | 0.115 | 0.126 | 0.156 | 0.061 | 0.274 | 0.201 | 0.172 | 0.148 | 0.209 | 0.28 | 0.307 | 0.393 | 0.38 | 0.351 | 0.345 | 0.176 |
Income Tax Expense
| 11.234 | 13.904 | 41.877 | 31.47 | 63.739 | 72.666 | 45.279 | 59.725 | 67.169 | 59.855 | 52.139 | 44.588 | 49.634 | 40.136 | 42.162 | 15.022 | 66.396 | 43 | 36.871 | 32.766 | 31.179 | 35.671 | 36.675 | 24.139 | 21.626 | 20.035 | 10.78 | 3.179 |
Net Income
| 99.653 | 105.282 | 120.626 | 93.658 | 145.319 | 241.787 | 137.126 | 180.151 | 208.109 | 197.184 | 155.89 | 143.556 | 165.202 | 192.731 | 220.958 | 82.598 | 307.466 | 201.827 | 157.848 | 112.355 | 132.044 | 128.681 | 108.685 | 118.854 | 112.652 | 98.189 | 92.488 | 31.378 |
Net Income Ratio
| 0.036 | 0.039 | 0.043 | 0.037 | 0.057 | 0.083 | 0.043 | 0.05 | 0.065 | 0.071 | 0.06 | 0.062 | 0.073 | 0.089 | 0.112 | 0.046 | 0.198 | 0.147 | 0.128 | 0.112 | 0.155 | 0.204 | 0.218 | 0.326 | 0.318 | 0.29 | 0.307 | 0.159 |
EPS
| 0.2 | 0.21 | 0.24 | 0.19 | 0.29 | 0.48 | 0.27 | 0.36 | 0.41 | 0.39 | 0.31 | 0.28 | 0.33 | 0.38 | 0.44 | 0.16 | 0.61 | 0.42 | 0.23 | 0.17 | 0.19 | 0.19 | 0.16 | 0.16 | 0.17 | 0.19 | 0.18 | 0.062 |
EPS Diluted
| 0.2 | 0.21 | 0.24 | 0.19 | 0.29 | 0.48 | 0.27 | 0.36 | 0.41 | 0.39 | 0.31 | 0.28 | 0.33 | 0.38 | 0.44 | 0.16 | 0.61 | 0.42 | 0.23 | 0.17 | 0.19 | 0.19 | 0.16 | 0.16 | 0.17 | 0.19 | 0.18 | 0.062 |
EBITDA
| 254.209 | 218.984 | 312.633 | 300.241 | 462.838 | 485.25 | 361.367 | 404.647 | 443.927 | 403.962 | 334.686 | 270.425 | 348.067 | 346.7 | 370.313 | 195.743 | 434.633 | 337.291 | 272.029 | 202.222 | 221.201 | 203.345 | 168.928 | 124.814 | 137.965 | 115.471 | 100.205 | 37.074 |
EBITDA Ratio
| 0.091 | 0.082 | 0.111 | 0.12 | 0.183 | 0.167 | 0.113 | 0.113 | 0.138 | 0.146 | 0.128 | 0.117 | 0.154 | 0.16 | 0.188 | 0.109 | 0.281 | 0.245 | 0.22 | 0.202 | 0.26 | 0.323 | 0.338 | 0.342 | 0.39 | 0.341 | 0.332 | 0.188 |